What is GLORY-1?
GLORY-1 is an innovative investigational therapy in the field of metabolic health, designed as a dual receptor agonist targeting both…
GLORY-1 is an innovative investigational therapy in the field of metabolic health, designed as a dual receptor agonist targeting both…
A landmark Phase 3 clinical study of mazdutide, the world’s first dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, has been…
Hi, I’m Mila —a recovering stress-eater, snack procrastinator, and occasional breakfast skipper. For years, I cycled through phases of “eating…
In the world of weight loss medications, Ozempic has gained a reputation as a game-changer. Originally developed to manage type…
Tokyo, Japan – A groundbreaking study from the University of Tokyo reveals that obesity causes temporary, but not permanent, disruptions in the…
Obesity isn’t just about weight—it’s a complex health condition with visible and hidden symptoms. Here are the most common signs your body…
In a proactive move to tackle rising health concerns among students, the Central Board of Secondary Education (CBSE) has directed…